The American Society of Transplant Surgeons is pleased to announce that Maggie Kebler-Bullock, CFRE, has been appointed as the ASTS Executive Director/CEO. She will formally step into the role on January 1, 2021.
Applications are invited December 1-31, 2020, for the AJT Editorial Fellowship, a program which offers a year-long editorial experience in the publication and peer review process to fellows and junior faculty in transplant-related fields.
ASTS is very pleased to see the U.S. House floor passage of H.R. 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (Immuno Bill), led by long-time congressional Bill champions Congressmen Ron Kind (D-WI) and Dr. Michael Burgess, M.D. (R-TX).
ASTS is excited to announce a new benefit for all active members. As a transplant team member, you may be required to travel for procurement on a moment’s notice. We have acquired additional insurance coverage to protect you and your loved ones if something were to happen to you while traveling for your work.